Reading time: 9 minutes

Chronic pain is one of the most under-addressed clinical areas in healthcare systems globally. Over the past two decades, China has established standalone pain medicine departments in major tertiary hospitals (often as independent pain clinics or as anaesthesia-pain divisions), and leading centres now perform the full range of interventional pain procedures — nerve blocks, radiofrequency ablation, pulsed radiofrequency, intradiscal therapies, spinal cord stimulation (SCS), and intrathecal drug delivery pumps — at international technical standards [1]. One important difference international patients must understand: China regulates opioid analgesics far more tightly than most Western countries — this materially affects what kinds of pain care can realistically be delivered cross-border. This article works through which chronic pain scenarios are appropriate for cross-border travel, the procedures available, the realistic limits on opioid therapy, and typical costs.

1. Scenarios Where Travelling to China for Pain Care Can Make Sense

  1. Chronic low back pain (discogenic or facet-mediated) — interventional therapy
  2. Trigeminal neuralgia — radiofrequency lesioning, balloon compression, or microvascular decompression
  3. Postherpetic neuralgia — pulsed radiofrequency or nerve block
  4. Complex regional pain syndrome (CRPS)
  5. Refractory cancer pain — intrathecal pump
  6. Failed back surgery syndrome — spinal cord stimulation

2. Interventional Techniques Available

Technique Indication Availability in China
Nerve block Acute or chronic pain Universal
Radiofrequency ablation (RFA) Facet-joint pain, neurogenic pain Established at leading centres
Pulsed radiofrequency (PRF) Neuropathic pain Established at leading centres
Intradiscal electrothermal therapy / nucleoplasty Discogenic back pain Selected centres
Percutaneous endoscopic discectomy Disc-related radiculopathy Widely available
Spinal cord stimulation (SCS) Failed back surgery, CRPS, neuropathic pain Leading centres
Intrathecal drug delivery pump Refractory cancer pain, spasticity Leading centres
Trigeminal microvascular decompression / balloon compression Trigeminal neuralgia Neurosurgery departments

3. Opioid Analgesics — The China vs Home-Country Difference You Need to Understand

China’s regulation of opioid analgesics is materially stricter than most Western countries [2]:

  1. Morphine, oxycodone, fentanyl: all prescribable, but only at qualifying hospitals and within strict dose and quantity limits
  2. Oxycontin (controlled-release oxycodone): available
  3. Hydromorphone, buprenorphine patches: available at selected centres
  4. Crossing borders with opioid medication: requires a physician’s English-language letter and customs declaration; quantities above personal-use thresholds can be confiscated [3]
  5. Long-term outpatient opioid prescribing: tightly controlled; usually requires inpatient initiation or specialist outpatient programmes

Practical implications for international patients:

  1. Do not travel to China expecting to obtain a large opioid supply to bring home — this is not realistic
  2. For chronic cancer pain or refractory pain syndromes, leading Chinese centres can initiate intrathecal pumps or interventional therapy as an alternative to systemic opioid escalation

4. Hospitals to Consider

Hospital City
PLA General Hospital (301), Department of Pain Medicine Beijing
Peking University Third Hospital, Department of Pain Medicine Beijing
Xuanwu Hospital, Capital Medical University, Pain Medicine Beijing
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Pain Medicine Shanghai
West China Hospital, Pain Medicine Chengdu
Sun Yat-sen Third Hospital, Pain Medicine Guangzhou
Tenth People’s Hospital affiliated to Tongji University, Pain Medicine Shanghai

5. Typical Process

Interventional treatment of chronic pain (5–7 days):

  1. Days 1–2: pain assessment and imaging (MRI / CT)
  2. Days 3–4: interventional procedure (nerve block / radiofrequency)
  3. Days 5–7: observation and adjustment

Spinal cord stimulation implantation (10–14 days):

  1. Days 1–3: preoperative evaluation
  2. Days 4–7: trial stimulation with external leads for approximately one week
  3. Days 8–10: permanent implantation
  4. Days 11–14: recovery and discharge

6. Typical Costs (USD, 1 USD = 6.5 RMB)

Item Public tertiary international dept. High-end private
Pain specialist consultation 80–250 150–500
Single nerve block 200–600 400–1,000
Radiofrequency ablation (joint / nerve) 800–2,500 1,500–4,500
Pulsed radiofrequency 1,000–2,500 1,500–4,500
Endoscopic discectomy 5,500–9,000 9,000–14,000
Spinal cord stimulation (with device) 18,000–28,000 25,000–40,000
Intrathecal pump implantation (with device) 14,000–22,000 22,000–35,000

US reference:

  1. SCS total cost typically USD 70,000–100,000 [4]
  2. Intrathecal pump USD 60,000–90,000

7. Handing Care Back Home

  1. SCS and intrathecal pumps require long-term management by a pain physician or neurosurgeon in your home country
  2. Before departure you must confirm your home country has the resources to maintain the device (charging, drug refilling, lead programming)
  3. Do not undergo implantation if you cannot identify a home-country facility able to service the device

8. What MedCareInChina Can and Cannot Do on the Pain Pathway

Our two products are Remote Consultation and In-China Accompanied Care.

  1. Remote Consultation: a USD 800 single-expert consultation with a pain specialist who reviews your records and gives an initial view on plan
  2. In-China Accompanied Care: hospital accompaniment with translation through evaluation, interventional procedures, and implant surgery

What we do not do: opioid prescription handling, cross-border medication transport, long-term pain management.

9. Action Checklist

  1. Bring 6 months of pain diary, imaging, and medication history
  2. Engage a remote consultation to assess interventional suitability
  3. Before implantation: confirm device service resources exist in your home country
  4. Apply for an S2 visa
  5. Plan 5–14 days in China

Sources

[1] Chinese Medical Doctor Association Pain Medicine Society — Clinical guidance for pain medicine: https://www.cmda.cn/ [2] National Medical Products Administration of China — Regulations on the administration of narcotic and psychotropic drugs: https://www.nmpa.gov.cn/ [3] General Administration of Customs of the PRC — Declaration of narcotic and psychotropic medications carried in personal luggage: http://www.customs.gov.cn/ [4] North American Neuromodulation Society — Therapy guidelines and references: https://www.neuromodulation.org/